RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/SHA-384/1E580D5841B4BD560F39DE6F8A55FDE0C987BAA285AA61B938CBAF10170B564C65F9B471D0BAE9E7A9AAE419C40E95E1http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/1E580D5841B4BD560F39DE6F8A55FDE0C987BAA285AA61B938CBAF10170B564C65F9B471D0BAE9E7A9AAE419C40E95E1http://www.w3.org/2000/01/rdf-schema#comment"We found that pro-inflammatory cytokines IL-6 and CCL2 suppressed PER2 gene expression. Mechanistic studies further revealed that IL-6/STAT3/NFkappaB p50 and CCL2/PI3K/AKT signaling pathways suppressed PER2 gene expression in both phenotypically normal MCF-10A cells as well as MCF-7 breast cancer cells."xsd:string
http://purl.uniprot.org/uniprot/#_A8E1B1A71FE8EB4698198A8C35E6D5DD5D7ECB576BC43369B4EE1F165CA7490587E281674540209BECC5606A22508001http://www.w3.org/1999/02/22-rdf-syntax-ns#subjecthttp://purl.uniprot.org/SHA-384/1E580D5841B4BD560F39DE6F8A55FDE0C987BAA285AA61B938CBAF10170B564C65F9B471D0BAE9E7A9AAE419C40E95E1
http://purl.uniprot.org/uniprot/Q6UZ82http://purl.uniprot.org/core/mappedAnnotationhttp://purl.uniprot.org/SHA-384/1E580D5841B4BD560F39DE6F8A55FDE0C987BAA285AA61B938CBAF10170B564C65F9B471D0BAE9E7A9AAE419C40E95E1
http://purl.uniprot.org/uniprot/#_Q6UZ82-mappedCitation-30343691http://purl.uniprot.org/core/mappedAnnotationhttp://purl.uniprot.org/SHA-384/1E580D5841B4BD560F39DE6F8A55FDE0C987BAA285AA61B938CBAF10170B564C65F9B471D0BAE9E7A9AAE419C40E95E1